Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03041077 · ClinicalTrials.gov registry record · NA
Influence of Instaflex Advanced Supplement on Joint Function
A NA study, sponsored by Appalachian State University.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT03041077 is a NA study that has completed, run by Appalachian State University. The registered enrollment target is 66 participants.
The verdict
NCT03041077, a NA study, has completed, sponsored by Appalachian State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
Joint discomfort is reported by 32% of U.S. adults, and increases with age. The knee is the most common site of joint discomfort regardless of age. Nearly half of people with knee joint discomfort use natural supplements to alleviate symptoms, but more research is needed to determine their effectiveness. In a previous study, we measured the effect of 8-weeks ingestion of a commercialized joint support dietary supplement (InstaflexTM Joint Support, Direct Digital, Charlotte, NC) compared to placebo on joint discomfort, stiffness, and function in adults with self-reported joint discomfort. This study will be repeated using Instaflex Advanced, with a longer 12-week time period. The Instaflex Advanced supplement includes six products: turmeric, resveratrol, Boswellia serrata, collagen, hyaluronic acid, and black pepper extract. This unique blend may improve joint function and increase mobility, but has not yet been tested in humans using a randomized, double-blinded, placebo-controlled research design. The primary purpose of this study is to assess the effect of 12-weeks ingestion of the Instaflex Advanced supplement compared to placebo in improving knee function in adults with self-reported knee joint discomfort.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Instaflex Advanced
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2017-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03041077
The ClinicalTrials.gov registry entry for NCT03041077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Appalachian State University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03041077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03041077 about?
NCT03041077 is a clinical study titled "Influence of Instaflex Advanced Supplement on Joint Function". Joint discomfort is reported by 32% of U.S. adults, and increases with age. The knee is the most common site of joint discomfort regardless of age. Nearly half of people with knee joint discomfort use natural supplements to alleviate symptoms, but more research is needed to determine their effective...
What is the current status of trial NCT03041077?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2017-02-01. Estimated completion is 2017-09-30.
What interventions are being tested in trial NCT03041077?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Instaflex Advanced (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03041077?
This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.